Sanos Clinic’s Post

Sanos Clinic reposted this

We are super excited to share that our pioneering trial, PAKOA-001, has successfully screened and randomized its first participants at the Sanos Clinic in Herlev, Denmark! 🎉 PAKOA-001 is the first study to evaluate an innovative and easy-to-use approach for managing treatment expectations within a placebo-controlled trial, with the intent of reducing the placebo response and increase our ability to detect true effects of efficacious treatments. Through advanced sensory testing and detailed patient-reported measures, this project will provide critical insights into how study participants report their pain and how that affects the placebo response - insights that could transform how clinical trials are conducted worldwide. With a goal to enroll 150 participants across our three Sanos Clinics, this study reflects our commitment to making a meaningful impact on new treatment possibilities for patients in need. Led by our PhD Fellow Jakob Mejdahl Bentin, MD, supported by the NBCD and Sanos Science team, the project is partially funded by the Innovation Foundation Denmark. We’re also honored to collaborate with top experts, including Prof. Lars Arendt-Nielsen, a global expert in pain research at Aalborg University, and Prof. Lene Vase from Aarhus University, a global thought-leading scientist on placebo effects. At Sanos Group we are dedicated to advancing science and creating solutions that make a real difference. Stay tuned for more milestones to come! #ClinicalTrials #PlaceboResearch #NBCD #PatientImpact #partofSanosGroup  

  • No alternative text description for this image

Hope it goes well, Asger. Congratulations!

Super Asger and team! Already curious to see the results then!

Like
Reply
Ivailo Tzanev

Medical Advisor at Clinic Design ltd

2mo

Congratulations Asger, placebo response has been a trouble for so many products and any breakthrough on the topic may result in a worldwide vibrance ...so much awaited!!🤞🤞🤞

Like
Reply
Henning Heiberg Andersen

Chief Financial Officer & Board Person

2mo

Congrats Asger & team. You are making a difference!

Like
Reply
Stuart Ratcliffe

Chief Scientific Officer, St Pancras Clinical Research

5d

Very impressive. We used Nat Katz’s FAST test at screening to eliminate likely placebo responders in a published OA trial to good effect.

See more comments

To view or add a comment, sign in

Explore topics